166 related articles for article (PubMed ID: 19488416)
1. Anti-leishmanial effects of trinitroglycerin in BALB/C mice infected with Leishmania major via nitric oxide pathway.
Nahrevanian H; Najafzadeh M; Hajihosseini R; Nazem H; Farahmand M; Zamani Z
Korean J Parasitol; 2009 Jun; 47(2):109-15. PubMed ID: 19488416
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of anti-leishmanial activity by induction of nitric oxide and inhibition of prostaglandin in Balb/c mice infected with Leishmania major.
Nahrevanian H; Hajihosseini R; Arjmand M; Farahmand M; Ghasemi F
Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1188-98. PubMed ID: 20578452
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Bemani E; Oryan A; Bahrami S
Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
[TBL] [Abstract][Full Text] [Related]
5. Fe3O4
Albalawi AE; Khalaf AK; Alyousif MS; Alanazi AD; Baharvand P; Shakibaie M; Mahmoudvand H
Biomed Pharmacother; 2021 Jul; 139():111566. PubMed ID: 33839494
[TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activity of Urtica dioica extract against zoonotic cutaneous leishmaniasis.
Badirzadeh A; Heidari-Kharaji M; Fallah-Omrani V; Dabiri H; Araghi A; Salimi Chirani A
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007843. PubMed ID: 31929528
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of anti-leishmanial effects of killed Leishmania vaccine with BCG adjuvant in BALB/c mice infected with Leishmania major MRHO/IR/75/ER.
Nahrevanian H; Jafary SP; Nemati S; Farahmand M; Omidinia E
Folia Parasitol (Praha); 2013 Feb; 60(1):1-6. PubMed ID: 23539946
[TBL] [Abstract][Full Text] [Related]
8. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
9. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
10. Moroccan strains of Leishmania major and Leishmania tropica differentially impact on nitric oxide production by macrophages.
Maksouri H; Dang PM; Rodrigues V; Estaquier J; Riyad M; Akarid K
Parasit Vectors; 2017 Oct; 10(1):506. PubMed ID: 29061164
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of total phenolic fraction derived from extra virgin olive oil for its antileishmanial activity.
Koutsoni OS; Karampetsou K; Kyriazis ID; Stathopoulos P; Aligiannis N; Halabalaki M; Skaltsounis LA; Dotsika E
Phytomedicine; 2018 Aug; 47():143-150. PubMed ID: 30166099
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Murine Systemic Leishmaniasis by Acetyl Salicylic Acid via Nitric Oxide Immunomodulation.
Nahrevanian H; Jalalian M; Farahmand M; Assmar M; Rastaghi AE; Sayyah M
Iran J Parasitol; 2012; 7(2):21-8. PubMed ID: 23109942
[TBL] [Abstract][Full Text] [Related]
13. Infectivity of macrophages and the histopathology of cutaneous lesions, liver and spleen is attenuated by leaf extract of Vernonia amygdalina in Leishmania major infected BALB/c mice.
Alawa JN; Carter KC; Nok AJ; Kwanashie HO; Adebisi SS; Alawa CB; Clements CJ
J Complement Integr Med; 2012 Jun; 9():Article 10. PubMed ID: 22713278
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections.
Miguel DC; Zauli-Nascimento RC; Yokoyama-Yasunaka JK; Katz S; Barbiéri CL; Uliana SR
J Antimicrob Chemother; 2009 Feb; 63(2):365-8. PubMed ID: 19095684
[TBL] [Abstract][Full Text] [Related]
15. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
Schwartz J; Moreno E; Calvo A; Blanco L; Fernández-Rubio C; Sanmartín C; Nguewa P; Irache JM; Larrea E; Espuelas S
J Dermatol Sci; 2018 Oct; 92(1):78-88. PubMed ID: 30037731
[TBL] [Abstract][Full Text] [Related]
16. Stachys lavandulifolia Vahl. exhibits promising in vitro and in vivo antileishmanial activity against Leishmania major infection.
Alanazi AD; Albalawi AE; Almohammed HI; Shater AF
Trop Biomed; 2022 Sep; 39(3):412-420. PubMed ID: 36214438
[TBL] [Abstract][Full Text] [Related]
17. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species.
Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA
Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957
[TBL] [Abstract][Full Text] [Related]
18. Topical glyceryl trinitrate: a possible treatment for cutaneous leishmaniasis.
Zeina B; Banfield C; al-Assad S
Clin Exp Dermatol; 1997 Sep; 22(5):244-5. PubMed ID: 9536549
[TBL] [Abstract][Full Text] [Related]
19. Sambucus ebulus extract stimulates cellular responses in cutaneous leishmaniasis.
Heidari-Kharaji M; Fallah-Omrani V; Badirzadeh A; Mohammadi-Ghalehbin B; Nilforoushzadeh MA; Masoori L; Montakhab-Yeganeh H; Zare M
Parasite Immunol; 2019 Jan; 41(1):e12605. PubMed ID: 30472741
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).
Khan MA; Maruno M; Khaskhely NM; Ramzi ST; Hosokawa A; Uezato H; Landires EA; Hashiguchi Y; Nonaka S
Am J Trop Med Hyg; 2002 Aug; 67(2):184-90. PubMed ID: 12389945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]